13 Dec 2019,
  • HSI:
    26,980.33 334.90 (1.26%)
    HSCI:
    10,620.61 118.08 (1.12%)
    HKSPLC25:
    35,403.11 418.84 (1.20%)
    HKSPGEM:
    77.39 0.61 (0.79%)
  • HSCEI:
    10,620.61 118.08 (1.12%)
    HSCCI:
    4,336.24 48.61 (1.13%)
    HSFML25:
    9,382.86 98.90 (1.07%)
    H-FIN:
    16,562.66 141.44 (0.86%)
  • Hang Seng Index
  • 26,980.33

  • 334.90 (1.26%)
HSCI 10,620.6 118.1
HKSPLC25 35,403.1 418.8
HKSPGEM 77.4 0.6
HSCEI 10,620.6 118.1
HSCCI 4,336.2 48.6
HSFML25 9,382.9 98.9
H-FIN 16,562.7 141.4
Stay Connected With EQS TodayIR

Tianda Pharmaceuticals Limited (00455.HK)

Health Care
+ More Circulars

INTRADAY CHART

more

FINANCIAL REPORTSmore

2018 (AR)
2018 (IR)
2018 (AR)

PRESENTATIONSmore

  • 2013/14 Annua ...
    2014
  • 2013 Interim ...
    2013
  • 2012/13 Annua ...
    2013
Tianda Pharmaceuticals Ltd (Tianda Pharmaceuticals) is engaged in the research and development, manufacture and sales of pharmaceutical, biotechnology and healthcare products.

Headquartered in Hong Kong, Tianda Pharmaceuticals has set up sales and distribution centres in Shenzhen and Sydney, and established two pharmaceutical R&D and production bases in Zhuhai and Kunming. Both production bases are awarded Good Manufacturing Practice ("GMP") certifications issued by China Food and Drug Administration ("CFDA"). The production base in Zhuhai is even awarded GMP certification by Therapeutic Goods Administration ("TGA") of Australia.

Tianda Pharmaceuticals is listed on the Hong Kong Stock Exchange (Stock Code: 00455.HK). Tianda Group is its controlling stakeholder with a 55.56% stake.
+ More Company Profile

Mr. Alan Fang -

Executive Director, Chairman and Managing Director, the chairman of the nomination committee and a member of the remuneration committee and the risk management committee of Tianda Pharmaceuticals Limted, as well as a director of the Tianda Pharmaceuticals’ certain subsidiaries. Mr. Fang is the founder, chairman and beneficial owner of Tianda Group Limited, the controlling shareholder of Tianda Pharmaceuticals. Mr. Fang is also the chairman of the board of directors, General Manager and authorised representative of Tianda Culture Holdings (China) Limited (listed on the National Equities Exchange and Quotations Systems, NEEQ Company Code: 837889). He has extensive experience in corporate strategy and management. He studied international relations in the University of Sydney and Tsinghua University. Mr. Fang has established a non-profit organisation “Tianda Institute”, a think tank of strategic studies. With the mission of “Care for a Better World”, Mr. Fang is devoted to social welfare, including poverty alleviation, education, medical, scientific research, environmental protection and culture, etc.

Mr. Warwick Lui -

Executive Director of Tianda Pharmaceuticals Limted and Deputy General Manager of Tianda Group Limited, Mr. Lui is responsible for the financial issues of Tianda Group and Tianda Phamaceuticals. Mr. Lui possesses enriched financial management experience covering a variety of industries including auditing in one of the Big Four accounting firms in Hong Kong and overseeing the finance department of a Hong Kong-listed company. Mr. Lui obtained Executive Master of Business Administration (“EMBA”) degree from City University of Hong Kong. He is a fellow member of the Association of Chartered Certified Accountants and the Hong Kong Institute of Certified Public Accountants (“HKICPA”).

Ms. Wendy Wu -

Chief Financial Officer of Tianda Pharmaceuticals Limted, Ms. Wu is responsible for the financial management and capital operation of Tianda Pharmaceuticals. Ms. Wu has extensive experience in financing, mergers and acquisitions, compliance, corporate operations and strategy. She served as Chief Financial Officer of a Hong Kong-listed company. Ms. Wu obtained her bachelor’s degree in international trade and her master’s degree in accounting practice from Monash University, Australia. She is currently a certified practicing accountant of CPA Australia and a member of the HKICPA.

Mr. Wang Jiarun -

Executive Deputy General Manager of Tianda Pharmaceuticals (China) Limted, Mr. Wang oversees the marketing strategy and implementation in China market. Mr. Wang possesses solid clinician and pharmaceutical marketing and operation experience. Mr. Wang served a range of pharmaceutical companies in China by taking up various senior management positions. Mr. Wang obtained his bachelor’s degree in medicine from Chengdu University of Traditional Chinese Medicine.

Mr. Qian Kun -

Executive Deputy General Manager of Tianda Pharmaceutical (Zhuhai) Limted, Mr. Qian is responsible for the overall management of Tianda Pharmaceutical (Zhuhai) and the construction of the new plant in Zhuhai. Mr. Qian has extensive experience in pharmaceutical procurement, research and development (“R&D”), manufacturing, plant construction and operation management. He served as senior management in a renowned domestic pharmaceutical company. Mr. Qian obtained his bachelor's degree in Chinese medicine from Nanjing University of Chinese Medicine and his master's degree in clinical pharmacy from Soochow University.

Ms. Wu Sujie -

Deputy General Manager of Yunnan Meng Sheng Pharmaceutical Company Limted, Ms. Wu is responsible for the overall management of Meng Sheng Pharmaceutical. Ms. Wu possesses enriched experience in quality management of pharmaceutical manufacturing. She served as senior management in various foreign and domestic listed pharmaceutical companies, mainly engaged in quality assurance, R&D, drug administration, procurement, logistics, etc. Ms. Wu led her project team to successfully obtain the Australian Certificate of Good Manufacturing Practice (“GMP Certificate”) and new version of Chinese GMP certificates several times. Ms. Wu obtained her bachelor’s degree in biology from Shaanxi Normal University. She holds the qualifications of senior pharmaceutical engineer and licensed pharmacist.

Mr. Di Ming -

General Manager of Tianda Chinese Medicine (China) Limted, Mr. Di is responsible for the overall operation and management of Tianda Chinese Medicine (China). He possesses rich experience in trend and information analysis, variety research, planting, breeding, and management in Chinese herbal medicine industry. He served as senior management in domestic Chinese medicine information companies, Chinese medicine trading platform companies and listed pharmaceutical companies, mainly engaged in Chinese medicine information analysis and variety research, trading platform construction, capital operation, etc. Mr. Di graduated from Bengbu Medical College and obtained his bachelor's degree from Market Economy Academy of Peking University.

Mr. Zeng Yunbiao -

Deputy General Manager of TDMall (China) Limited, Mr. Zeng is responsible for the overall management and operation of TDMall (China). He has extensive experience in marketing and manufacturing in terms of traditional Chinese Medicine (“TCM”) and healthcare product industry, establishment of TCM centers, preparation and construction of healthcare product factories and processed Chinese herbal medicine factories, etc. Mr. Zeng obtained his bachelor’s degree in pharmacy from Jiangxi University of Traditional Chinese Medicine. He holds the qualifications of pharmaceutical engineer and licensed pharmacist.

Mr. Yan Daishan -

Deputy General Manager of Zhuhai Tianda Processed Chinese Herbal Medicine Limted, Mr. Yan is responsible for the overall management of Tianda Processed Chinese Herbal Medicine. Mr. Yan has extensive experience in processing, manufacturing, technology, quality control of TCM decoction pieces as well as construction of processed Chinese herbal medicine factories. He served as senior management in many processed Chinese herbal medicine companies, overseeing the manufacturing, quality assurance and product mix enrichment. Mr. Yan obtained his bachelor’s degree in Chinese Medicine from Guangxi University of Chinese Medicine, and then completed the certificate courses of Master of Business Administration (“MBA”) at Renmin University of China College of Continuing Education. He holds the qualification of licensed pharmacist (TCM).

Ms. Yang Yuhua -

Executive Deputy General Manager of Tianda Chinese Medicine Institute Limited, Ms. Yang is responsible for the technology and product R&D of Chinese medicine as well as the construction of Chinese medicine research institution platform. Ms. Yang has extensive experience in drug R&D and scientific research management. She served as senior management in large domestic listed pharmaceutical companies, mainly engaged in drug R&D, development of technology and standards, registration, project management, etc. She chaired and was responsible for a number of major provincial and municipal science and technology projects and won many achievements and honors. Ms. Yang obtained her bachelor’s degree in medicine from the School of Pharmacy, Xi'an Medical University, and her master’s degree from the School of Pharmacy, Lanzhou University. She holds the qualifications of senior engineer at professor grade and licensed pharmacist.

Ms. Xie Bin -

Deputy General Manager of Tianda Pharmaceutical (Zhuhai) Limted, Ms. Xie is responsible for new drug R&D. Ms. Xie processes enriched experience in drug R&D and production quality management. She served as senior management in foreign-funded and domestic listed pharmaceutical companies, mainly engaged in R&D, quality control, manufacturing, and overall management of pharmaceutical factories. Ms. Xie obtained her master’s degree in medicine from Changchun University of Chinese Medicine. She holds the qualifications of senior pharmaceutical engineer and licensed pharmacist.
+ More Board of Directors
Audit Committee

The management staff are properly serving their roles and responsibilities by reviewing and monitoring the duties of the appointed auditor on the basis of independence, objective and validity; examining the annual and interim Financial Statements before submission for Board of Directors ‘approval; and reviewing the financial control, internal audit and risk management system of the company.

Audit Committee Members
Mr. Lam Yat Fai– INED (Chairman)
Mr. Shen Bo– NED
Mr. Chiu Sung Hong– INED
Mr. Chiu Fan Wa– INED

 
Nomination Committee

Set up to nominate, review and discuss about candidacy for Board of Directors, evaluate the independence of the Independent Non-Executive Director and propose appointment to the Board of Directors.

Nomination Committee Members
Mr. Fang Wen Quan – Executive Director (Chairman)
Mr. Lam Yat Fai – INED
Mr. Chiu Sung Hong– INED

 
Risk Management Committee

Set up to assist the Board of Directors to take heed of and make informed decision on operational risks, design the risk management strategy direction and risk control management system in an attempt to reduce the operational risk to the minimum.

Risk Management Committee members
Mr. Chiu Sung Hong – INED (Chairman)
Mr. Fang Wen Quan – Executive Director
Mr. Lam Yat Fai – INED

 
Remuneration Committee

Set up to propose the remuneration policy and framework for Directors and senior management staff.

Remuneration Committee Members
Mr. Chiu Sung Hong –INED(Chairman)
Mr. Fang Wen Quan – Non-Executive Director
Mr. Lam Yat Fai –INED
Mr. Chiu Fan Wa –INED

 
 
 

UPCOMING EVENT

S M T W T F S
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31        

COMPANY INFORMATION

Listed Date 30 Mar 1992

Address Level 24, CITIC Tower,
No. 1 Tim Mei Avenue,
Central, Hong Kong

Telephone (852) 2545-3313

Facsimile (852) 2545-6558

Email [email protected]

No. of Click Rate

301982